1 / 12

The Biogenic Eye

Mike DeSalvio, Michael Nguyen, Khine Win, Kevin Ip , John Chi. The Biogenic Eye. Who. Patients suffering from non-preventable blindness in one eye Not designed for completely blind Must currently retain the original eye to prevent muscle atrophy for attachment

prem
Télécharger la présentation

The Biogenic Eye

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mike DeSalvio, Michael Nguyen, Khine Win, Kevin Ip, John Chi The Biogenic Eye

  2. Who • Patients suffering from non-preventable blindness in one eye • Not designed for completely blind • Must currently retain the original eye to prevent muscle atrophy for attachment • Screened for compatibility with blood thinners • In 2002 roughly 161 million visually impaired world wide. (W.H.O.) • Of this 124 million had low vision • And 37 million are blind • Childhood blindness in 2002 reached 3.9% • 47% caused by cataracts Michael N

  3. What • Bionic prosthetic camera mounted within a silicon based plastic casing • Contains an internal reservoir with a lacrimating compound for lubrication • Signal Processor • Radio antenna • Muscular attachments Michael N

  4. Where • Mounted within the eye socket of the affected individual • Corresponding hardware is “installed” near the occipital lobe near brain stem • Utilizing current patent WO/1999/045870 • Delivery reservoir modification • Negotiate a non-exclusive licensing agreement with Johns Hopkins University for the current technology John http://www.wipo.int/pctdb/en/wo.jsp?WO=1999045870

  5. Why • Only 3.9% of children are born blind or developed blindness. Permanent loss of sight • Most adults loose sight because of Cataracts (48%) and Glaucoma (12%) • Macular degeneration, corneal opacity, and diabetes <10% John

  6. Why • Provide a prosthetic alternative to clinical blindness to improve quality of life. • Allow for more mobility • Able to drive • Depth perception • Night vision (not like night vision goggles) Kevin

  7. When • Total development time is 5 years • Engineering time • In vivo testing • By using an existing patent, development time is significantly shorter • ~1- 2 years Kevin

  8. How • The device works by transmitting a visual image from a camera into a processor and through the optic nerve. Khine

  9. Quality Function Deployment Mike D

  10. Analysis • Highest preference was performance and lowest preference was style • Ability to see in darker atmospheres significantly outweighed alternatives • Iris color was the least concerned benefit, correlating to the customer preference Mike D

  11. Expanded QFD • See Document… Mike D

  12. Questions

More Related